| |
| |
|
| Insider
Information: |
Van Nostrand Robert L |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
479,433 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$23,537 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
479,433 |
|
|
| Total
Value |
$23,537 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apex Bioventures Acquisition Corp |
PEX.WS |
Director |
2007-06-07 |
152,277 |
|
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
Director |
2024-03-28 |
48,635 |
2012-11-30 |
0 |
Premium* |
|
|
Enumeral Biomedical Holdings, Inc. |
ENUM |
Director |
2017-01-03 |
268,121 |
2016-12-09 |
0 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
|
2020-01-28 |
0 |
2018-12-14 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2024-01-22 |
10,400 |
2022-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2024-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,924 |
48,635 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2024-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
10,400 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
18,879 |
36,711 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
13,868 |
17,832 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,040 |
3,964 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
4,400 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
1,900 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2020-01-28 |
4 |
D |
$6.30 |
$252,000 |
D/D |
(40,000) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2019-12-18 |
4 |
OE |
$3.28 |
$65,600 |
D/D |
20,000 |
40,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2018-12-14 |
4 |
OE |
$1.05 |
$21,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2017-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
43,155 |
46,488 |
0 |
- |
|
| ENUM |
Enumeral Biomedical Holdi... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
66,666 |
268,121 |
0 |
- |
|
| ENUM |
Enumeral Biomedical Holdi... |
Director |
– • – |
2016-12-09 |
4 |
OE |
$0.13 |
$19,500 |
D/D |
156,000 |
201,455 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2015-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
31,250 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2012-11-30 |
4 |
B |
$1.07 |
$21,400 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| PEX.WS |
Apex Bioventures Acquisit... |
Director |
– • – |
2007-06-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
152,277 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
